\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/c\ \(14\)\
\-\ initial\\ multiple\\ mr\\ images\\ demonstrate\\ a\\ ring\\-enhancing\\ lesion\\ in\\ the\\ site\\ of\\ glioma\\,\\ previously\\ treated\\ with\\ radiation\\ therapy\\,\\ with\\ some\\ areas\\ of\\ nodular\\ changes\\.\\ \\ \ \(0\)\
\-\ mr\\ spectroscopy\\ of\\ normal\\ site\\,\\ te\\ \\=\\ 144\\ msec\\,\\ which\\ demonstrates\\ prominent\\ n\\-acetylaspartate\\ \\(naa\\)\\ peak\\ at\\ the\\ 2\\.0\\ ppm\\,\\ which\\ is\\ the\\ normal\\ neuronal\\ marker\\.\\ \\ creatine\\ peak\\ at\\ 3\\.0\\ ppm\\ and\\ choline\\ peak\\ at\\ 3\\.2\\ ppm\\ are\\ also\\ demonstrated\\,\\ showing\\ normal\\ relationships\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ of\\ the\\ abnormal\\ site\\,\\ te\\ \\=\\ 144\\ msec\\,\\ which\\ demonstrates\\ elevation\\ of\\ the\\ choline\\ peak\\,\\ and\\ the\\ suppression\\ of\\ the\\ naa\\ peak\\,\\ along\\ with\\ an\\ inverted\\ peak\\ at\\ the\\ 1\\.0\\-1\\.2\\ ppm\\,\\ which\\ is\\ the\\ lactate\\ peak\\ \\(which\\ characteristically\\ inverts\\ at\\ te\\ \\=\\ 144\\ msec\\)\\.\\ \\ these\\ findings\\ suggest\\ tumor\\ recurrence\\ with\\ some\\ areas\\ of\\ necrosis\\,\\ rather\\ than\\ radiation\\-induced\\ changes\\.\ \(0\)\
\-\ recurrent\\ high\\-grade\\ astrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ residual\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ recurrent\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ radiation\\ effect\ \(0\)\
\-\ \\â\\€\\¢\\ normal\\ brain\ \(0\)\
\-\ \\â\\€\\¢\\ post\\-operative\\ changes\ \(0\)\
\-\ 38\\ y\\.o\\.\\ white\\ male\\ with\\ previously\\ diagnosed\\ high\\-grade\\ glioma\\ in\\ the\\ left\\ parietal\\ lobe\\,\\ s\\/p\\ radiation\\ treatment\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ peak\\:\\ 0\\.45117968183238044\ \(0\)\
\-\ ppm\\:\\ 0\\.3619451330241412\ \(0\)\
\-\ msec\\:\\ 0\\.30176938957628563\ \(0\)\
\-\ te\\:\\ 0\\.2485298115508174\ \(0\)\
\-\ 144\\:\\ 0\\.2373994412789338\ \(0\)\
\-\ naa\\:\\ 0\\.17355231966414822\ \(0\)\
\-\ choline\\:\\ 0\\.1706075420944724\ \(0\)\
\-\ radiation\\:\\ 0\\.16672940997658048\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.16358465866649552\ \(0\)\
\-\ site\\:\\ 0\\.1521903881730049\ \(0\)\
\-\ which\\:\\ 0\\.14300486195032855\ \(0\)\
\-\ the\\:\\ 0\\.1255070478326944\ \(0\)\
\-\ mr\\:\\ 0\\.12209629151256186\ \(0\)\
\-\ at\\:\\ 0\\.11878945426250602\ \(0\)\
\-\ changes\\:\\ 0\\.11404128099147502\ \(0\)\
\-\ glioma\\:\\ 0\\.10686596228027395\ \(0\)\
\-\ normal\\:\\ 0\\.10272557494292493\ \(0\)\
\-\ previously\\:\\ 0\\.1009859808650372\ \(0\)\
\-\ recurrent\\:\\ 0\\.10086898816013905\ \(0\)\
\-\ inverts\\:\\ 0\\.10058979652542854\ \(0\)\
\-\ tumor\\:\\ 0\\.09870007016186112\ \(0\)\
\-\ relationships\\:\\ 0\\.0904862832560353\ \(0\)\
\-\ creatine\\:\\ 0\\.08677615983207411\ \(0\)\
\-\ of\\:\\ 0\\.0861639072555073\ \(0\)\
\-\ areas\\:\\ 0\\.08540862917999435\ \(0\)\
\-\ some\\:\\ 0\\.07915134987583405\ \(0\)\
\-\ inverted\\:\\ 0\\.07913314709297793\ \(0\)\
\-\ neuronal\\:\\ 0\\.07699227869826614\ \(0\)\
\-\ lactate\\:\\ 0\\.0763620193574255\ \(0\)\
\-\ characteristically\\:\\ 0\\.07520025777784295\ \(0\)\
\-\ suppression\\:\\ 0\\.07414931659415158\ \(0\)\
\-\ marker\\:\\ 0\\.07149013435388175\ \(0\)\
\-\ demonstrates\\:\\ 0\\.06319992572899945\ \(0\)\
\-\ with\\:\\ 0\\.061582421549686246\ \(0\)\
\-\ elevation\\:\\ 0\\.057344014082256325\ \(0\)\
\-\ residual\\:\\ 0\\.05723537737516843\ \(0\)\
\-\ 38\\:\\ 0\\.05581717315428522\ \(0\)\
\-\ rather\\:\\ 0\\.055722524190511845\ \(0\)\
\-\ showing\\:\\ 0\\.05430919573206764\ \(0\)\
\-\ recurrence\\:\\ 0\\.05193191474075682\ \(0\)\
\-\ suggest\\:\\ 0\\.051095683417561384\ \(0\)\
\-\ parietal\\:\\ 0\\.05079021965729672\ \(0\)\
\-\ nodular\\:\\ 0\\.05008988676602394\ \(0\)\
\-\ prominent\\:\\ 0\\.04953844503436904\ \(0\)\
\-\ necrosis\\:\\ 0\\.04807951145141567\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.04748333725850844\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04556260907652578\ \(0\)\
\-\ effect\\:\\ 0\\.04412308629687294\ \(0\)\
\-\ initial\\:\\ 0\\.042195307148066116\ \(0\)\
\-\ along\\:\\ 0\\.04214017435032521\ \(0\)\
\-\ white\\:\\ 0\\.04149922668128729\ \(0\)\
\-\ brain\\:\\ 0\\.03921130529965218\ \(0\)\
\-\ treated\\:\\ 0\\.03916921923109373\ \(0\)\
\-\ demonstrated\\:\\ 0\\.038656264577172736\ \(0\)\
\-\ abnormal\\:\\ 0\\.037789103257326095\ \(0\)\
\-\ lobe\\:\\ 0\\.03634919324877201\ \(0\)\
\-\ therapy\\:\\ 0\\.03613977135779882\ \(0\)\
\-\ than\\:\\ 0\\.035655868325415625\ \(0\)\
\-\ these\\:\\ 0\\.035519268052369414\ \(0\)\
\-\ is\\:\\ 0\\.03445084327838375\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0326996425423119\ \(0\)\
\-\ in\\:\\ 0\\.03129464714256857\ \(0\)\
\-\ findings\\:\\ 0\\.031043365293050063\ \(0\)\
\-\ multiple\\:\\ 0\\.030765454071053404\ \(0\)\
\-\ lesion\\:\\ 0\\.030155360410811315\ \(0\)\
\-\ treatment\\:\\ 0\\.029962310654385198\ \(0\)\
\-\ also\\:\\ 0\\.02958606413187899\ \(0\)\
\-\ images\\:\\ 0\\.029095149334538554\ \(0\)\
\-\ male\\:\\ 0\\.028005222123518123\ \(0\)\
\-\ and\\:\\ 0\\.025994772228168248\ \(0\)\
\-\ an\\:\\ 0\\.024052510501241638\ \(0\)\
\-\ are\\:\\ 0\\.02386745279865623\ \(0\)\
\-\ left\\:\\ 0\\.021456349216917168\ \(0\)\
